Analysis of pleural fluid biomarkers for diagnosis of malignant pleural effusion and molecular characterization of lung cancer: a review

Key Points

• The aim is to evaluate the effectiveness of pleural fluid biomarkers in diagnosing malignant pleural effusions and characterizing lung cancer at the molecular level.
• Review of existing literature on pleural fluid biomarkers
• Analysis of standardization and validation protocols for testing
• Examination of potential molecular targets for targeted therapies
• Pleural fluid analysis is a minimally invasive method for diagnosing malignant pleural effusions.
• Advancements in testing protocols could improve early diagnosis and treatment personalization.
• Identification of molecular targets in lung cancer could enhance the effectiveness of therapies.